We are excited to announce the appointment of Mr. Sandip Patel as the Chief Executive Officer (CEO) of BIOVERIC Pharmaceuticals, Inc. Mr. Patel brings a wealth of experience and a proven track record of drug product development and commercialization in the pharmaceutical industry. His expertise in patient-centric drug development and commitment to innovation aligns perfectly with our mission and vision.
“I am honored to lead such a dynamic company. I look forward to building a team and working with the partners at BIOVERIC Pharmaceuticals to develop innovative, patient-focused drug products that improve healthcare outcomes.”
— Mr. Sandip Patel, Chief Executive Officer
Please join us in welcoming Mr. Sandip Patel to his new role as CEO of BIOVERIC Pharmaceuticals, Inc.
BIOVERIC's programs are investigational product candidates. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency, and their safety and effectiveness have not been established.
← All news